Acta Pharm. 69 (2019) 249-259

 

full paper

Original research paper

 

Stability-indicating HPLC-PDA assay for simultaneous determination of paracetamol, thiamine and pyridoxal phosphate in tablet formulations

AMIR ALI, MUHAMMAD MAKSHOOF ATHAR, MAHMOOD AHMED, KASHIF NADEEM, GHULAM MURTAZA, UMAR FAROOQ and MUHAMMAD SALMAN

umar.chem@pu.edu.pk

1 Institute of Chemistry, University of the Punjab, Lahore 54590, Pakistan

2 Schazoo Pharmaceutical Laboratories, Lahore- Jaranwala Road, Sheikhupura, Pakistan

Accepted November 12, 2018

Published online December, 2018

 

With the increased number of multi-drug formulations, there is a need to develop new methods for simultaneous determinations of drugs. A precise, accurate and reliable liquid chromatographic method was developed for simultaneous determination of paracetamol, thiamine, and pyridoxal phosphate in pharmaceutical formulations. Separation of analytes was carried out with an Agilent Poroshell C18 column. A mixture of ammonium phosphate buffer (pH = 3.0), acetonitrile and methanol in the ratio of 86:7:7 (V/V/V) was used as the mobile phase pumped at a flow rate of 1.8 mL min-1. Detection of all three components, impurities and degradation products was performed at the selected wavelength of 270 nm. The developed method was validated in terms of linearity, specificity, precision, accuracy, LOD and LOQ as per ICH guidelines. Linearity of the developed method was found in the range 17.5-30 g mL1 for thiamine, 35-60 g mL1 for pyridoxal phosphate and 87.5-150 g mL1 for paracetamol. The coefficient of determination was ≥0.9981 for all three analytes. The proposed HPLC method was found to be simple and reliable for the routine simultaneous analysis of paracetamol, thiamine and pyridoxal phosphate in tablet formulations. Complete separation of analytes in the presence of degradation products indicated selectivity of the method.

 

Keywords: paracetamol, thiamine, pyridoxine phosphate, degradation, HPLC-PDA